Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conference Houston, TX, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that...

PetCure Oncology Continues to Drive Radiation Therapy for Pets with 3,000th Treatment Deerfield, IL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- National pet cancer care provider PetCure Oncology treated its 3,000th pet with advanced radiation therapy on Wednesday, reaching a historic...

PetCure Oncology Announces Capital Raise with Plans for Public Offering, Expansion of Pet Cancer Network Deerfield, IL, July 17, 2019 (GLOBE NEWSWIRE) -- PetCure Oncology, LLC, a company providing veterinary cancer treatment utilizing non-surgical stereotactic radiosurgery (SRS) and stereotactic...

PetCure Oncology Engages Boustead Securities, LLC for Regulation D 506(C) Offering and Planned National Exchange Listing Irvine, CA, July 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Boustead Securities, LLC announced today that it has entered into an engagement agreement with PetCure Oncology, LLC, a company...

PetCure Oncology and Nanovi Announce PetXmark™ Partnership to Introduce Fiducial Guided Stereotactic Radiotherapy for Pet Patients with Cancers Chicago, IL and Copenhagen, Denmark, Dec. 07, 2017 (GLOBE NEWSWIRE) -- PetCure Oncology Inc. (PetCure) and Nanovi A/S (Nanovi) announced an exclusive agreement to use PetXmark™ in the development...